Originally put into effect in 2017, the Protecting Access to Medicare Act (PAMA) requires many labs to report private payer data for clinical diagnostic lab tests to CMS every three years. The data is used to determine median payments in an effort to bring the...
The following is a column from Mick Raich, former President of RCM Consulting for Lighthouse Lab Services. In 2020 and early 2021, more than $4 trillion was pumped directly into society, including funding for healthcare providers and facilities. While most Americans...
While the legal intent of the Eliminating Kickbacks in Recovery Act (EKRA) overlaps in several areas with existing Anti-Kickback Statute (AKS), EKRA is separate offense with some substantial distinctions that serve to make the law more stringent for laboratories than...
Although the Eliminating Kickbacks in Recovery Act (EKRA) was first put into effect in 2018, there has been significant uncertainty concerning how the beefed-up anti-kickback rule will be applied as the Covid-19 Public Health Emergency winds down. With the DOJ now...
How antibody testing can bolster your lab’s revenue stream With Covid-19 diagnostic testing numbers declining throughout the country as vaccines proliferate, and the Center for Disease Control recommending vaccinated individuals skip testing, now is a good time for...
After previously stating its intent to stop paying the professional component of clinical pathology (PC/CP), Cigna has reversed course and will continue paying for these services after receiving significant pushback from the College of American Pathologists and others...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy